Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$987M |
| 2 |
Salesforce
CRM
|
+$660M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$586M |
| 4 |
HCA Healthcare
HCA
|
+$513M |
| 5 |
Netflix
NFLX
|
+$372M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$815M |
| 2 |
Incyte
INCY
|
+$811M |
| 3 |
NVIDIA
NVDA
|
+$514M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$493M |
| 5 |
MetLife
MET
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.63% |
| 2 | Technology | 14.62% |
| 3 | Industrials | 7.95% |
| 4 | Healthcare | 7.93% |
| 5 | Energy | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
ASE Group
ASX
$103B
| $4.22M | ﹤0.01% |
542,395
+13,577
| +3% | +$104K |
|
|
GRID
2177
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund
GRID
$12.2B
| $4.22M | ﹤0.01% |
40,181
+3,504
| +10% | +$347K |
|
2178
FlexShares Ultra-Short Income Fund
RAVI
$1.5B
| $4.22M | ﹤0.01% |
56,358
-1,853
| -3% | -$139K |
|
2179
US Foods
USFD
$23.6B
| $4.2M | ﹤0.01% |
95,556
+67,801
| +244% | +$2.69M |
|
2180
BlackRock Corporate High Yield Fund
HYT
$1.36B
| $4.2M | ﹤0.01% |
471,122
+26,429
| +6% | +$229K |
|
2181
Mercer International
MERC
$31.6M
| $4.2M | ﹤0.01% |
520,478
+383,759
| +281% | +$3.48M |
|
2182
Core & Main
CNM
$8.61B
| $4.2M | ﹤0.01% |
133,947
+119,560
| +831% | +$3.2M |
|
2183
Global X Copper Miners ETF NEW
COPX
$7.98B
| $4.2M | ﹤0.01% |
111,530
+9,562
| +9% | +$367K |
|
2184
Hillman Solutions
HLMN
$1.69B
| $4.19M | ﹤0.01% |
465,332
+45,209
| +11% | +$377K |
|
2185
Coty
COTY
$2.51B
| $4.19M | ﹤0.01% |
340,916
-547,906
| -62% | -$6.47M |
|
2186
Arcos Dorados Holdings
ARCO
$1.67B
| $4.18M | ﹤0.01% |
407,431
+12,743
| +3% | +$109K |
|
2187
MP Materials
MP
$10.5B
| $4.18M | ﹤0.01% |
182,531
+15,126
| +9% | +$347K |
|
2188
Fidelity MSCI Financials Index ETF
FNCL
$2.43B
| $4.15M | ﹤0.01% |
88,096
-4,848
| -5% | -$220K |
|
2189
iShares MSCI China A ETF
CNYA
$206M
| $4.14M | ﹤0.01% |
141,825
+47,697
| +51% | +$1.48M |
|
2190
Neurocrine Biosciences
NBIX
$15.5B
| $4.14M | ﹤0.01% |
43,895
-73,828
| -63% | -$7.21M |
|
2191
PUT
Algonquin Power & Utilities
AQN
$4.53B
| $4.13M | ﹤0.01% |
+500,000
| New | +$4.25M |
|
|
ITCI
2192
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4.13M | ﹤0.01% |
65,216
+10,467
| +19% | +$652K |
|
2193
AGNC Investment
AGNC
$13B
| $4.13M | ﹤0.01% |
407,443
+22,824
| +6% | +$222K |
|
|
EOI
2194
Eaton Vance Enhanced Equity Income Fund
EOI
$824M
| $4.12M | ﹤0.01% |
250,073
-18,563
| -7% | -$290K |
|
2195
Mesa Laboratories
MLAB
$593M
| $4.12M | ﹤0.01% |
32,031
-381
| -1% | -$58.1K |
|
|
MRO
2196
PUT
DELISTED
Marathon Oil Corporation
MRO
| $4.11M | ﹤0.01% |
+178,700
| New | +$4.21M |
|
2197
iShares MSCI South Korea ETF
EWY
$27.8B
| $4.11M | ﹤0.01% |
64,778
-177,158
| -73% | -$11.1M |
|
2198
Bruker
BRKR
$8.79B
| $4.1M | ﹤0.01% |
55,466
+8,051
| +17% | +$614K |
|
2199
Pacer Industrial Real Estate ETF
INDS
$116M
| $4.1M | ﹤0.01% |
104,671
-218,436
| -68% | -$8.71M |
|
|
WIRE
2200
DELISTED
Encore Wire Corp
WIRE
| $4.09M | ﹤0.01% |
21,993
-6,255
| -22% | -$1.06M |
|
Similar funds
Royal Bank of Canada's Q2 2023 Portfolio in Review
As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Royal Bank of Canada's Q2 2023 filing shows 676 new, 3,797 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.
- Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
- Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
- Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
- Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
- Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
- Royal Bank of Canada opened 676 new positions and closed 409 in Q2 2023.
- Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.
Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.